About Pricing FAQs Providers Trials Blog

Back to your record

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Prostate Cancer Clinical Trials in Colorado | 365 Studies

Clinical Trials Prostate CancerColorado

Prostate Cancer Clinical Trials in Colorado

Find 365 clinical trials for prostate cancer near Colorado. Connect with research centers in your area.

All Prostate Cancer trials nationwide All trials in Colorado

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 121-140 of 365 trials

RecruitingAn Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.The purpose of this study is to evaluate the efficacy and safety of lutetium (177Lu) vipivotide tetraxetan (AAA617) in participants with oligometastatic prostate cancer (OMPC)…NCT05939414·Fayetteville, Arkansas and 143 others

Prostate Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

RecruitingThe Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)The Phase 2 monotherapy portion of this study is currently enrolling and will evaluate the efficacy and safety of PC14586 (INN rezatapopt) in participants with locally advanced or…NCT04585750·Irvine, California and 75 others

RecruitingTesting Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate CancerThis phase III trial compares stereotactic body radiation therapy (SBRT), (five treatments over two weeks using a higher dose per treatment) to usual radiation therapy (20 to 45…NCT05946213·Birmingham, Alabama and 435 others

Active not recruitingA Clinical Study Evaluating The Benefit of Adding Rucaparib to Enzalutamide for Men With Metastatic Prostate Cancer That Has Become Resistant To Testosterone-Deprivation TherapyThis randomized, placebo-controlled phase III trial is evaluating the benefit of rucaparib and enzalutamide combination therapy versus enzalutamide alone for the treatment of men…NCT04455750·Anchorage, Alaska and 413 others

UnknownClariCore Optical Biopsy System Used in TRUS (Trans-Rectal Ultrasound)-Guided Prostrate BiopsyThe purpose of the study is to collect information on prostrate biopsy tissue for use in developing a method determining the difference in normal and cancerous prostrate tissue…NCT02928640·Denver, Colorado and 4 others

RecruitingStudy of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate CancerAssessment of the safety and efficacy of HLD-0915 (JNJ-101556143) in patients with metastatic prostate cancer who have progressed on prior systemic therapies, with further…NCT06800313·Colorado Springs, Colorado and 17 others

Active not recruitingStudy of Capivasertib + Docetaxel vs Placebo + Docetaxel as Treatment for Metastatic Castration Resistant Prostate Cancer (mCRPC)This study will assess the efficacy and safety of capivasertib plus docetaxel versus placebo plus docetaxel in participants with metastatic castration resistant prostate cancer…NCT05348577·Yuma, Arizona and 216 others

CompletedZoledronate in Treating Patients With Solid Tumors That Have Spread to the BoneRATIONALE: Zoledronate may help to relieve some of the symptoms caused by bone metastases.NCT00003884·Birmingham, Alabama and 54 others

RecruitingZEN003694 and Enzalutamide Versus Enzalutamide Monotherapy in Metastatic Castration-Resistant Prostate CancerThis is an open-label, randomized, Phase 2b study of ZEN003694 in combination with enzalutamide vs. enzalutamide monotherapy in patients with mCRPC who have progressed on prior…NCT04986423·Los Angeles, California and 30 others

CompletedThe Efficacy and Safety of Degarelix One Month Dosing Regimens in Prostate CancerThe study was a three-arm, active-control, multi-centre, parallel group study.NCT00295750·Homewood, Alabama and 34 others

CompletedRadiation Therapy With or Without Bicalutamide for Recurrent pT3N0 Prostate Cancer After Radical ProstatectomyRATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. Androgens can stimulate the growth of prostate cancer cells.NCT00002874·Birmingham, Alabama and 239 others

RecruitingTargeted Treatment for Metastatic Prostate Cancer, The PREDICT TrialThis phase II trial evaluates whether genetic testing in prostate cancer is helpful in deciding which study treatment patients are assigned.NCT06632977·Birmingham, Alabama and 107 others

CompletedPROCLAIM: Germline Genetic Testing for Prostate Cancer PatientsThis registry is for men who have prostate cancer and have had multigene panel hereditary testing.NCT05447637·San Diego, California and 18 others

CompletedOpen-label Trial on the Effect of I.V. Zoledronic Acid 4 mg on Bone Density in Hormone Sensitive Prostate Cancer Patients With Bone MetastasisThe purpose of this trial with Zometa is to investigate the effect ZOMETA 4 mg (zoledronic acid for injection in 100mg solution ) has in preventing associated bone loss in…NCT00035997·Birmingham, Alabama and 55 others

CompletedA Trial of Talabostat (BXCL701) and Pembrolizumab in Participants With Metastatic Castrate-Resistant Prostate Cancer (mCRPC) Either Small Cell Neuroendocrine Prostate Cancer or Adenocarcinoma PhenotypeAn open-label, multicenter, Phase 1b/2 study to identify the recommended Phase 2 dose and assess the efficacy and safety of talabostat administered orally, as monotherapy and in…NCT03910660·San Francisco, California and 11 others

TerminatedExtension Study Investigating the Long-Term Safety and Tolerability of Repeat Doses of FE200486 in Prostate Cancer PatientsParticipants responding well in Study FE200486 CS06 (NCT00117949) were given the opportunity to continue treatment with degarelix under a clinical study until FE200486 was…NCT00117312·Anaheim, California and 11 others

RecruitingA Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other TumorsThe main purpose of this study is to determine the safety, tolerability (how the body reacts to the drug\[s\]) and effectiveness (ability to treat the cancer) of REGN5678…NCT03972657·Gilbert, Arizona and 26 others

RecruitingDose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid TumorsThis study is designed to characterize the safety, tolerability, and anti-tumor activity of MDX2001 in patients with advanced solid tumors.NCT06239194·Denver, Colorado and 5 others

CompletedS0354, Anti-IL-6 Chimeric Monoclonal Antibody in Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone TherapyRATIONALE: Monoclonal antibodies, such as anti-IL-6 chimeric monoclonal antibody, can block tumor growth in different ways.NCT00433446·Anniston, Alabama and 122 others

CompletedHormone Therapy Plus Chemotherapy in Treating Patients With Prostate CancerRATIONALE: Androgens can stimulate the growth of prostate cancer cells.NCT00030654·Phoenix, Arizona and 77 others

PreviousPage 7 of 19Next

Other Conditions in Colorado

Breast Cancer Lung Cancer Colorectal Cancer Melanoma Leukemia Lymphoma